Michael LaBarre
Chief Tech/Sci/R&D Officer at HALOZYME THERAPEUTICS, INC.
Net worth: 6 M $ as of 2024-04-29
Michael LaBarre active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 | - |
| General Counsel | - | 2019-12-31 | |
| Corporate Officer/Principal | 2008-06-15 | 2015-08-23 |
Career history of Michael LaBarre
Former positions of Michael LaBarre
| Companies | Position | Start | End |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2003-11-30 | 2006-03-31 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 1995-10-31 | 2003-11-30 |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - | - |
Training of Michael LaBarre
| University of Arizona | Doctorate Degree |
| Stony Brook University | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Michael LaBarre
- Experience